These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 23306656)

  • 1. The puzzle of TRPV4 channelopathies.
    Nilius B; Voets T
    EMBO Rep; 2013 Feb; 14(2):152-63. PubMed ID: 23306656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Channelopathies converge on TRPV4.
    Nilius B; Owsianik G
    Nat Genet; 2010 Feb; 42(2):98-100. PubMed ID: 20104247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPV4-pathy, a novel channelopathy affecting diverse systems.
    Dai J; Cho TJ; Unger S; Lausch E; Nishimura G; Kim OH; Superti-Furga A; Ikegawa S
    J Hum Genet; 2010 Jul; 55(7):400-2. PubMed ID: 20505684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPV4-mediated channelopathies.
    Verma P; Kumar A; Goswami C
    Channels (Austin); 2010; 4(4):319-28. PubMed ID: 20676052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients.
    Cho TJ; Matsumoto K; Fano V; Dai J; Kim OH; Chae JH; Yoo WJ; Tanaka Y; Matsui Y; Takigami I; Monges S; Zabel B; Shimizu K; Nishimura G; Lausch E; Ikegawa S
    Am J Med Genet A; 2012 Apr; 158A(4):795-802. PubMed ID: 22419508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations.
    Leddy HA; McNulty AL; Lee SH; Rothfusz NE; Gloss B; Kirby ML; Hutson MR; Cohn DH; Guilak F; Liedtke W
    FASEB J; 2014 Jun; 28(6):2525-37. PubMed ID: 24577120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human skeletal dysplasia causing L596P-mutant alters the conserved amino acid pattern at the lipid-water-Interface of TRPV4.
    Das R; Mohanta S; Dubey NK; Das NK; Goswami C
    Biochim Biophys Acta Biomembr; 2023 Feb; 1865(2):184085. PubMed ID: 36403799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPV4-associated skeletal dysplasias.
    Nishimura G; Lausch E; Savarirayan R; Shiba M; Spranger J; Zabel B; Ikegawa S; Superti-Furga A; Unger S
    Am J Med Genet C Semin Med Genet; 2012 Aug; 160C(3):190-204. PubMed ID: 22791502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo
    Ragamin A; Gomes CC; Bindels-de Heus K; Sandoval R; Bassenden AV; Dib L; Kok F; Alves J; Mathijssen I; Medici-Van den Herik E; Eveleigh R; Gayden T; Pullens B; Berghuis A; van Slegtenhorst M; Wilke M; Jabado N; Mancini GMS; Gomez RS
    J Med Genet; 2022 Mar; 59(3):305-312. PubMed ID: 33685999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.
    Rock MJ; Prenen J; Funari VA; Funari TL; Merriman B; Nelson SF; Lachman RS; Wilcox WR; Reyno S; Quadrelli R; Vaglio A; Owsianik G; Janssens A; Voets T; Ikegawa S; Nagai T; Rimoin DL; Nilius B; Cohn DH
    Nat Genet; 2008 Aug; 40(8):999-1003. PubMed ID: 18587396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.
    Taga A; Peyton MA; Goretzki B; Gallagher TQ; Ritter A; Harper A; Crawford TO; Hellmich UA; Sumner CJ; McCray BA
    Ann Clin Transl Neurol; 2022 Mar; 9(3):375-391. PubMed ID: 35170874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the TRPV4-RhoA complex offer clues to solve the puzzle of TRPV4 channelopathies.
    Hu X; Hu H
    Cell Calcium; 2023 Dec; 116():102814. PubMed ID: 37839180
    [No Abstract]   [Full Text] [Related]  

  • 13. TRPV4: Molecular Conductor of a Diverse Orchestra.
    White JP; Cibelli M; Urban L; Nilius B; McGeown JG; Nagy I
    Physiol Rev; 2016 Jul; 96(3):911-73. PubMed ID: 27252279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.
    Auer-Grumbach M; Olschewski A; Papić L; Kremer H; McEntagart ME; Uhrig S; Fischer C; Fröhlich E; Bálint Z; Tang B; Strohmaier H; Lochmüller H; Schlotter-Weigel B; Senderek J; Krebs A; Dick KJ; Petty R; Longman C; Anderson NE; Padberg GW; Schelhaas HJ; van Ravenswaaij-Arts CM; Pieber TR; Crosby AH; Guelly C
    Nat Genet; 2010 Feb; 42(2):160-4. PubMed ID: 20037588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygous TRPV4 mutations in two siblings with a complex phenotype including severe intellectual disability and neuropathy.
    Thibodeau ML; Peters CH; Townsend KN; Shen Y; Hendson G; Adam S; Selby K; Macleod PM; Gershome C; Ruben P; Jones SJM; ; Friedman JM; Gibson WT; Horvath GA
    Am J Med Genet A; 2017 Nov; 173(11):3087-3092. PubMed ID: 28898540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TRPV4 in skeletal function and its mutant-mediated skeletal disorders.
    Das R; Goswami C
    Curr Top Membr; 2022; 89():221-246. PubMed ID: 36210150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal neuropathy-associated TRPV4 regulates neurotrophic factor-derived axonal growth.
    Jang Y; Jung J; Kim H; Oh J; Jeon JH; Jung S; Kim KT; Cho H; Yang DJ; Kim SM; Kim IB; Song MR; Oh U
    J Biol Chem; 2012 Feb; 287(8):6014-24. PubMed ID: 22187434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls.
    Fawcett KA; Murphy SM; Polke JM; Wray S; Burchell VS; Manji H; Quinlivan RM; Zdebik AA; Reilly MM; Houlden H
    J Neurol Neurosurg Psychiatry; 2012 Dec; 83(12):1204-9. PubMed ID: 22851605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of novel mutation in TRPV4 with familial nonsyndromic craniosynostosis with complete penetrance and variable expressivity.
    Gayden T; Crevier-Sorbo G; Jawhar W; Saint-Martin C; Eveleigh R; Gilardino MS; Anastasio N; Trakadis Y; Bassenden AV; Berghuis AM; Jabado N; Dudley RWR
    J Neurosurg Pediatr; 2023 Jun; 31(6):584-592. PubMed ID: 36905673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in TRPV4 results in altered chondrocyte calcium signaling in severe metatropic dysplasia.
    Hurd L; Kirwin SM; Boggs M; Mackenzie WG; Bober MB; Funanage VL; Duncan RL
    Am J Med Genet A; 2015 Oct; 167A(10):2286-93. PubMed ID: 26249260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.